In that single-arm study, the rate of primary adverse events within 7 days of ablation was 2.9%, with the most common ...

The FDA approved a wide range of therapies in 2024, including many new molecular entities and biological products.

Atrial fibrillation is the most common arrhythmic ... it is imperative for the clinician to be informed about these arrhythmias and treatment considerations. This paper presents a basic review ...

Such techniques can be automatically applied using implantable cardioverter defibrillators (ICDs) and offer the potential for painless termination of ventricular tachycardia (VT). Reduction in ...

Twelve-lead ECG tracing during stress test shows the typical aspect of bidirectional ventricular tachycardia characterized by 180 ... 0.67), suggesting to intensify the treatment in these cases. 35 An ...